Radium-223 dichloride with enzalutamide for treating asymptomatic or mildly symptomatic hormone-relapsed metastatic prostate cancer with bone metastases [ID6512]

  • Awaiting development
  • GID-TA11657
  • Expected publication date: 

Documents

Documents created during the development process.

Notes

Referral